Literature DB >> 15292309

Impact of ovarian hyperstimulation on thyroid function in women with and without thyroid autoimmunity.

Kris Poppe1, Daniel Glinoer, Herman Tournaye, Johan Schiettecatte, Paul Devroey, Andre van Steirteghem, Patrick Haentjens, Brigitte Velkeniers.   

Abstract

Pregnancy is accompanied by changes in thyroid function, but limited data are available on these changes in the very first weeks of pregnancy. Yet, T(4) plays a major role in implantation and early fetal development. We sought to determine thyroid function during this period and during the first trimester, in pregnancies achieved by assisted reproductive technology. Furthermore, the thyroid hormone profile was compared between euthyroid women with (TAI+) and without (TAI-) thyroid autoimmunity. We prospectively analyzed data from 35 women who received ovarian hyperstimulation (OH) and presented clinical pregnancies. The mean age of the women was 32 +/- 5 yr. Thyroid function tests [serum TSH and free T(4) (FT(4))] and thyroid antibody status were determined before OH (baseline values) and every 20 d after ovulation induction during the first trimester of pregnancy. Serum TSH and FT(4) increased significantly at d 20, compared with baseline values (3.3 +/- 2.4 vs. 1.8 +/- 0.9 mU/liter; P < 0.0001 and 13.2 +/- 1.7 vs. 12.4 +/- 1.9 ng/liter; P = 0.005). During the first trimester of pregnancy, there was a significant change over time for TSH and FT(4) (P < 0.001 and P = 0.005, respectively). Nine women (27%) were TAI+. The TSH curve among these TAI+ women was significantly higher compared with TAI- women (P = 0.010). The opposite was observed for the FT(4) curve (P = 0.020). In conclusion, the present study showed a significant increase of serum TSH and FT(4) levels after OH in the very first period of pregnancy compared with pre-OH levels and a significant impact of TAI on the thyroid hormone profile during the first trimester. This provides evidence for an altered thyroid function in euthyroid TAI+ patients.

Entities:  

Mesh:

Year:  2004        PMID: 15292309     DOI: 10.1210/jc.2004-0105

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization.

Authors:  Clarisa R Gracia; Christopher B Morse; Grace Chan; Samantha Schilling; Maureen Prewitt; Mary D Sammel; Susan J Mandel
Journal:  Fertil Steril       Date:  2012-01-18       Impact factor: 7.329

2.  Effect of autoimmune thyroid disease in older euthyroid infertile woman during the first 35 days of an IVF cycle.

Authors:  Andrea Reh; Sonal Chaudhry; Felicia Mendelsohn; Shelly Im; Linda Rolnitzky; Alana Amarosa; Mortimer Levitz; Suman Srinivasa; Lewis Krey; Alan S Berkeley; James A Grifo; Ann Danoff
Journal:  Fertil Steril       Date:  2010-11-03       Impact factor: 7.329

3.  Female infertility: do we forget the thyroid?

Authors:  D Unuane; K Poppe
Journal:  J Endocrinol Invest       Date:  2015-04-07       Impact factor: 4.256

4.  2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction.

Authors:  Kris Poppe; Peter Bisschop; Laura Fugazzola; Gesthimani Minziori; David Unuane; Andrea Weghofer
Journal:  Eur Thyroid J       Date:  2021-01-21

5.  In vitro fertilization pregnancy rates in levothyroxine-treated women with hypothyroidism compared to women without thyroid dysfunction disorders.

Authors:  Bert Scoccia; Habibe Demir; Yuna Kang; Michelle A Fierro; Nicola J Winston
Journal:  Thyroid       Date:  2012-04-27       Impact factor: 6.568

6.  Thyroglobulin autoantibodies: is there any added value in the detection of thyroid autoimmunity in women consulting for fertility treatment?

Authors:  David Unuane; Brigitte Velkeniers; Ellen Anckaert; Johan Schiettecatte; Herman Tournaye; Patrick Haentjens; Kris Poppe
Journal:  Thyroid       Date:  2013-08       Impact factor: 6.568

7.  Supplemental iodine-containing prenatal multivitamins use and the potential effects on pregnancy outcomes in a mildly iodine-deficient region.

Authors:  F Guo; Y Liu; Z Ding; C Zhang; Z Liu; J Fan
Journal:  J Endocrinol Invest       Date:  2020-06-08       Impact factor: 4.256

8.  Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women.

Authors:  Aimee Seungdamrong; Anne Z Steiner; Clarisa R Gracia; Richard S Legro; Michael P Diamond; Christos Coutifaris; William D Schlaff; Peter Casson; Gregory M Christman; Randal D Robinson; Hao Huang; Ruben Alvero; Karl R Hansen; Susan Jin; Esther Eisenberg; Heping Zhang; Nanette Santoro
Journal:  Fertil Steril       Date:  2017-10-25       Impact factor: 7.329

Review 9.  Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence.

Authors:  Shakila Thangaratinam; Alex Tan; Ellen Knox; Mark D Kilby; Jayne Franklyn; Arri Coomarasamy
Journal:  BMJ       Date:  2011-05-09

10.  Impact of Thyroid Autoimmunity on In Vitro Fertilization/Intracytoplasmic Sperm Injection Outcomes and Fetal Weight.

Authors:  Ning Huang; Lixue Chen; Ying Lian; Haining Wang; Rong Li; Jie Qiao; Hongbin Chi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.